To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
As a native New Jerseyan, it is a privilege to join the faculty of the Rutgers Cancer Institute as the Director of the Melanoma/Cutaneous Oncology Program. I am a medical oncologist with clinical expertise in the treatment of advanced melanoma and other cutaneous malignancies (merkel cell, basal cell, and squamous cell carcinomas). My primary research interests are focused on developing innovative immunotherapeutic strategies to treat advanced skin cancers, particularly for those patients who have not responded to standard of care therapies. I have a passion for clinical research and am committed to providing the most personalized and up-to-date treatment for my patients, particularly in the form of clinical trials. Through this research, I aim to better understand why some patients’ tumors are resistant to certain therapies, and how we can overcome this resistance.
Prior to joining Rutgers, I was on the faculty at Yale Cancer Center where I treated patients with advanced melanoma and other skin cancers and conducted clinical and translational research. I received my undergraduate degree from the Rutgers College Honors Program at Rutgers University and my medical degree from the Albert Einstein College of Medicine, where I graduated with distinction in Oncology Research. I then completed my Internal Medicine residency at Montefiore Medical Center and a fellowship in Hematology and Medical Oncology at New York University School of Medicine, where I stayed on for an additional year of training to focus on melanoma translational research.
At Rutgers Cancer Institute of New Jersey, New Jersey’s only NCI-designated cancer center, I have the opportunity to work collaboratively with my colleagues in the Melanoma and Soft Tissue Oncology Program to provide comprehensive, coordinated, and multidisciplinary care for all of our skin cancer patients and to offer the opportunity for participation in clinical trials whenever possible.
Melanoma, merkel cell carcinoma, advanced skin cancers, immunotherapy, targeted therapy, clinical trials
August 20, 2024
Brilliant, compassionate, and kind.
August 15, 2024
Dr. Weiss has been excellent in every way.
July 9, 2024
Extremely patient centered - went out of her way to review scans with others for opinions.
April 30, 2024
Great visit from the moment I walked in the door. Everyone was very professional and very respectful.
April 16, 2024
I've been a regular at Rutgers CINJ for the last twenty years.
December 6, 2023
Dr. Weiss is an excellent physician kind, compassionate, patient & very knowledgeable. I highly recommend her to everyone.
December 4, 2023
She is very caring and sincere.
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.
How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Sarah Weiss, MD, medical oncologist at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, answers questions about skin cancer and sun protection that you may be wondering. Read more
New Ways to Treat Skin Cancer
Our patients have the benefit of advanced treatment options, clinical trials, and greater access to expert care. Read more
Dr. Sarah Weiss discusses the different types of skin cancer, latest treatment options and the importance of prevention